Quick Take
ICON plc (ICLR) has acquired MolecularMD for an undisclosed amount.
MolecularMD [MMD] has developed a full service diagnostics service line to accelerate oncology (cancer) drug approval.
With the deal for MMD, ICLR gains increased capabilities in the laboratory molecular diagnostics space for the growing field of personalized cancer treatments.
Target Company
Portland, Oregon-based MolecularMD was founded in 2005 to provide outsourced diagnostic services to biotech and pharmaceutical firms developing treatment candidates for various cancers.
Management is headed by president Dan Snyder, who has been with the firm since 2006
Below